Evaluating the Use of Predictive Models in Combination with In Vitro Assays

IIVS is excited to announce the publication of 2 papers evaluating the use of predictive models in combination with in vitro assays to provide a quantitative assessment of skin sensitization potential. This work is presented Drs. Frank Gerberick (GF3 Consultancy, Chief Scientific Advisor to IIVS) and Andreas Natsch (Senior Research Fellow at Givaudan )

Integrated Skin Sensitization Assessment Based on OECD Methods (I): Deriving a Point of Departure for Risk Assessment

Integrated Skin Sensitization Assessment Based on OECD Methods(II): Hazard and Potency by Combining Kinetic Peptide Reactivity and the “2 out of 3” Defined Approach